460. Disproportionalities in COVID-19 Clinical Drug Trials in the United States: A Systematic Literature Review

BACKGROUND: To combat higher rates of COVID-19 infection, hospitalization, and death among minorities, it is crucial to identify safe, efficacious, and generalizable treatments. Therefore, the purpose of this systematic literature review was to assess the demographic characteristics of COVID-19 clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chastain, Daniel B, Patel, Vishwa S, Jefferson, Alexandria M, Osae, Sharmon P, Chastain, Joeanna S, Martínez, Andrés F Henao, Franco-Paredes, Carlos, Young, Henry N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690674/
http://dx.doi.org/10.1093/ofid/ofab466.659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690674/
http://dx.doi.org/10.1093/ofid/ofab466.659

Ejemplares similares